Next Article in Journal
Laboratory Surveillance of Bovine Brucellosis: Predictors of Rose Bengal Test Positivity in Mpumalanga Province, South Africa (2021–2024)
Next Article in Special Issue
A Case of Avian Influenza Co-Infection and Multifactorial Diseases in a Broiler Chicken Farm in Majalengka, West Java, Indonesia
Previous Article in Journal
Effects of Black Soldier Fly Larvae as Replacement of Soybean Meal on the Performance, Meat Quality, and Health Status in Broilers
Previous Article in Special Issue
Research Progress on Pathogenesis and Prevention of Avian Leukosis Virus J Subgroup (ALV-J)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preliminary Transcriptomic Insights into the Combined Pathogenesis of Avian Leukosis Virus and Salmonella pullorum Co-Infection

1
Chongqing Academy of Animal Sciences, Chongqing 402460, China
2
College of Animal Science, Southwest University, Chongqing 400715, China
3
Chongqing Engineering Research Center of Higher Education for Herbivore, Chongqing 400715, China
*
Authors to whom correspondence should be addressed.
Vet. Sci. 2026, 13(3), 283; https://doi.org/10.3390/vetsci13030283
Submission received: 14 January 2026 / Revised: 21 February 2026 / Accepted: 28 February 2026 / Published: 18 March 2026

Simple Summary

Co-infection with avian leukemia and Pullorum Disease poses a serious threat to poultry health. However, the combined pathogenic mechanism remains unclear, and no commercial vaccines or effective drugs are available. This study used transcriptome sequencing to identify differentially expressed genes and pathways related to immunity and tumorigenesis. The findings provide new insights into the co-infection mechanism and offer a theoretical basis for developing integrated control strategies in the poultry industry.

Abstract

Co-infection with avian leukemia and Pullorum Disease severely compromises poultry health, yet its pathogenic mechanisms remain unclear. We employed transcriptome sequencing to analyze gene expression changes and enriched pathways in kidney, spleen, and liver tissues of Chongqing Chengkou mountain chickens under single-infection (avian leukemia virus or Pullorum Disease) and co-infection conditions. Significant differences were observed in the number and pathways of differentially expressed genes between co-infected and single-infected groups. These genes were predominantly enriched in pathways involving extracellular matrix–receptor interactions, PPAR signaling, and calcium ion signaling. RT-qPCR validation confirmed significant upregulation of MAPK10 and SQLE, alongside downregulation of genes such as FOXG1. This study identifies multiple differentially expressed genes and pathways associated with immunity and tumorigenesis, providing crucial molecular insights into the regulatory mechanisms underlying avian leukemia and Pullorum Disease co-infection.

1. Introduction

Avian Leukemia (AL) and Pullorum Disease (PD) are two major infectious diseases that severely threaten the health of poultry in China. These diseases not only cause substantial economic losses to the poultry industry but also threaten the long-term sustainability and economic viability of China’s poultry farming sector [1,2]. AL and PD are caused by the avian leukosis virus (ALV) and Salmonella pullorum (S. pullorum), respectively. ALV, a member of the retrovirus family, induces immunosuppression, delays multi-organ development, and promotes tumorigenesis in the host, leading to reduced egg production, increased mortality, and higher culling rates [3]; S. pullorum is a Gram-negative intracellular bacterium [4] that primarily affects chicks, causing high mortality and reproductive disorders in breeding stock, thereby impairing chicken growth and development [3]. To date, no commercial vaccines or specific antiviral drugs are available for the prevention and control of AL. Although significant progress has been made in vaccine research for pullorum disease—particularly with the development of live [5], attenuated [6,7], and genetically engineered vaccines [8]—the complexity of S. pullorum and the influence of environmental factors [9] mean that prevention and control still require integration with biosecurity measures, rational drug use, and the development of novel vaccines and therapeutics to achieve more effective outcomes. Therefore, the most widely recognized and effective approach to controlling AL and PD is to implement purification measures starting from the breeding stock [10]. During recent purification efforts for AL and PD in the core breeding flock of Chengkou Mountain Chickens, we observed that these two diseases frequently co-occur: the infection rate of AL was significantly higher in flocks positive for PD than in those negative for it. Flocks co-infected with both diseases exhibited more severe clinical symptoms and significantly higher mortality rates than those infected with either disease alone. This finding aligns with the results reported by Huang et al. [11], based on testing of breeding flocks across multiple regions nationwide. Consequently, a thorough investigation into the regulatory mechanisms governing the interaction between AL and PD is crucial for the efficient development of integrated control strategies.
Much is known about how ALV and S. pullorum infect hosts individually [12,13]. However, their combined pathogenic mechanisms during co-infection are still unclear. Early studies have identified the potential threat of co-infection with ALV and S. pullorum to poultry health. Huang Jianqiang et al. [11] first detected co-infection with ALV-J and S. pullorum in chicken flocks in Shandong Province and developed relevant animal models. Jing Yuanyuan et al. [14] found that ALV-J infection causes immunosuppression and enhances S. pullorum colonization, while S. pullorum infection may increase ALV-J viral loads via inflammatory responses. These findings suggest a mutually reinforcing pathogenic relationship between the two pathogens. Recent research has increasingly focused on the immunological mechanisms driving this interaction. Ying Tang et al. [15] observed that S. pullorum infection shifts the immune response toward a Th2-dominant profile [16,17], characterized by decreased IFN-γ and increased IL-4 levels [18]. This immune polarization may facilitate persistent infection by these pathogens, highlighting the importance of understanding immune responses in managing co-infections in poultry.
Within the broader field of viral-bacterial co-infection research, evidence has emerged indicating that certain pathogen co-infections form immune–inflammatory interaction networks [19]. Viruses may influence host antibacterial immunity through pathways such as interferon signaling, while bacterial infections can modify the local microenvironment, thereby affecting viral replication. These mechanisms offer theoretical frameworks for understanding the complex interactions among different pathogens. However, in the context of ALV-S. pullorum co-infection, systematic genome-wide evidence is still lacking regarding the existence of such mutually reinforcing relationships, the specific molecular mechanisms involved, and how these interactions collectively reshape the host’s transcriptional regulatory networks across multiple organs [20].
Building on these findings, this study performed transcriptome sequencing on target organs from chicken populations infected with ALV alone, S. pullorum alone, and ALV-S. pullorum co-infection. By comparing immune-related pathways and tumor proliferation pathways across the three groups, we identified key regulatory factors and screened potential candidate genes associated with chicken immunity. These results provide a theoretical basis for further elucidating the molecular mechanisms underlying co-infection with AL and PD, thereby advancing understanding of pathogen interactions and host responses.

2. Materials and Methods

2.1. Ethical Statement for Laboratory Animals

All animals utilized in this study were obtained from the Chongqing Chengkou Mountain Chicken Genetic Resources Institute. The experimental procedures involving animals strictly complied with the Regulations on Laboratory Animal Management of Southwest University, along with all relevant rules and regulations. The research protocol was thoroughly reviewed and approved by the Animal Experiment Ethics Review Committee of Southwest University, receiving formal approval under the reference number SWU_LAC2025111041. Throughout the entire experimental process, the principles of the 3Rs—reduction, replacement, and refinement—were rigorously followed to ensure the highest standards of animal welfare and ethical research conduct.

2.2. Principal Instruments and Reagents

Information on the principal reagents and instruments used in this study is provided in Table 1 and Table 2.

2.3. Confirmation and Collection of Samples

2.3.1. Experimental Grouping

To investigate the combined pathogenic mechanism of co-infection by ALV and S. pullorum, this study established four experimental groups with clearly defined infection statuses based on serological diagnostic results. The procedure was as follows: First, a preliminary screening of the chicken population at the Chengkou Mountain Chicken Genetic Resource Center was conducted using the Salmonella pullorum plate agglutination test. Rectal swabs were collected from individuals testing positive in the agglutination test. Based on kit instructions and preliminary validation, the eluate obtained from these swabs was suitable for further testing. Subsequently, ALV antigen analysis was performed on these eluates using an ALV-p27 antigen ELISA detection kit. Based on the combined results of these tests, chickens were divided into four groups:
Group A (Co-infection group): Agglutination test (+), ALV antigen (+), n = 3.
Group B (Single ALV infection): Agglutination test (−), ALV antigen (+), n = 3.
Group C (Single S. pullorum infection): Agglutination test (+), ALV antigen (−), n = 3.
Group D (Healthy control): Agglutination test (−), ALV antigen (−), clinically asymptomatic, n = 3.

2.3.2. Sample Size and Experimental Design

The sample size for this study was limited to three chickens per group, primarily due to the practical challenges associated with screening and confirming pure single infections versus co-infections within field flocks. To maintain statistical rigor, each chicken was considered an independent biological replicate. All comparisons between groups and subsequent statistical analyses were performed at this biological replicate level. To gather more comprehensive information on host responses and improve data robustness within the constraints of a limited number of biological replicates, a multi-tissue sampling strategy was implemented. Tissue samples were collected from the liver, spleen, and kidneys of each chicken, resulting in a total of 36 samples for transcriptomic analysis. This approach allowed for a more detailed understanding of tissue-specific responses and increased the reliability of the data despite the small sample size.

2.3.3. Sample Collection

Chickens were anesthetized with intravenous sodium pentobarbital and euthanized by cervical bleeding. After confirming death, the abdominal cavity was incised along the medial thigh. Using sterile, autoclaved instruments, liver, spleen, and kidney tissues were aseptically collected from each chicken. The tissue blocks were rinsed with pre-chilled PBS, then cut into approximately 50 mg pieces and transferred to centrifuge tubes containing RNAlater RNA stabilizer. Following overnight stabilization at room temperature, the stabilizer was discarded, and tissue pieces were stored at −80 °C in an ultra-low temperature freezer.

2.4. RNA-Seq Library Preparation and Sequencing

The collected samples were sent to Novogene Bio-Technology Co., Ltd. (Beijing, China) for transcriptome sequencing. Upon receipt, RNA was extracted from the tissue using standard methods, followed by rigorous quality control, library preparation, and sequencing of the RNA samples, ensuring high-quality data for analysis.

2.5. Transcriptome Sequencing Data Analysis

Low-quality and contaminated reads were removed from the raw Fastq data using FastQC, based on specific criteria: reads containing adapter sequences, reads with N-base content exceeding 10%, and reads with low-quality bases (Q ≤ 5) accounting for over 50% were discarded, resulting in high-quality Clean Reads. Next, HISAT2 (v2.2.1) was used to align these Clean Reads to the chicken reference genome (GCF_016699485_2). Only reads successfully mapped to the genome were retained for further analysis. Gene expression quantification was performed with featureCounts (v2.0.6), producing raw counts for each gene, which served as input for DESeq2. Differential expression analysis was conducted using the DESeq2 R package (v1.42.0). This software models count data with a negative binomial distribution and normalizes raw counts using the Median of Ratios method to account for sequencing depth differences. Genes with significant differential expression were identified based on a Benjamini–Hochberg-corrected p-value (FDR or padj) ≤ 0.05 and an absolute log2(FoldChange) ≥ 1. For these genes, GO functional enrichment and KEGG pathway analyses were performed using the clusterProfiler R package (v4.8.1). The significance threshold for enrichment was set at a corrected p-value ≤ 0.05.

2.6. Candidate Gene Screening

To validate sequencing results and explore key mechanisms of co-infection, eight genes were selected from differential expression analysis for RT-qPCR validation. The criteria included genes with a corrected p-value ≤ 0.05 and |log2FC| ≥ 1. The selected genes also showed high magnitude of expression change and functional relevance to infection-related pathways like immunity, inflammation, or tissue remodeling.

2.7. Real-Time Quantitative PCR (RT-qPCR) Analysis

To validate the reliability of transcriptomic sequencing results, five randomly selected differentially expressed genes were analyzed using real-time quantitative PCR (RT-qPCR). Primers were designed for quantitative analysis, and log2 fold-change (log2FC) values were compared with the sequencing data. The qPCR conditions were as follows: 94 °C pre-denaturation for 30 s, 98 °C denaturation for 10 s, annealing at 56.8 °C for 30 s, and extension at 72 °C for 60 s, repeated for 35 cycles. Primer sequences are listed in Table 3.

3. Results

3.1. Quality Control Analysis of Transcriptome Data

Transcriptome sequencing of 36 samples yielded 239.62 gigabytes of high-quality reads for subsequent analysis, with each sample averaging over six gigabytes of data. All samples produced an average of 44.37 million clean reads, exhibiting an average data validity rate exceeding 96% and an average Q30 of 95.55%. Compared to the chicken reference genome, the average total mapping rate was 90.11%, with a unique mapping rate of 84.90%. Detailed data are presented in Appendix A and Appendix B.

3.2. Correlation Analysis Among Samples

Correlation matrices were constructed for the FPKM distributions of 36 samples using Pearson correlation and principal component analysis (PCA). Co-expression Venn diagrams were plotted for genes across different visceral groups. Results indicate that within the same visceral organ, samples from the same group exhibit high correlation coefficients, similar expression patterns, and good intra-group reproducibility (Figure 1A). Conversely, samples from different visceral organs show distinct distributions along PC1 and PC2 (Figure 1B), demonstrating high consistency in sequencing results across groups and strong reproducibility of sequencing data. Figure 2 clearly illustrates the similarities and differences in gene expression between the three treatment groups across kidney, spleen, and liver tissues: In kidney tissue, Group A shared the fewest co-expressed genes with Group D (only 84), while Group B shared the most (195). In the spleen, Group A and Group D shared the highest number of co-expressed genes (243), while Group B and Group D shared the fewest (112). In the liver, Group C and Group D shared the highest number of co-expressed genes (220), and Group B and Group D shared the fewest (75). These results indicate that the treatment effect of Group A exhibited the greatest differential expression in the kidney, while the treatment effect of Group B showed the greatest differential expression in both the spleen and liver.

3.3. Transcriptome Sequencing Differential Gene Expression Analysis

Differential gene expression analysis of kidneys, livers, and spleens from Groups A, B, and C was performed using DESeq2 software. The screening criteria included a corrected p-value ≤ 0.05 and an absolute log2 fold-change ≥ 1. In the kidneys, Group A exhibited 1816 differentially expressed genes (DEGs), with 969 upregulated and 847 downregulated. Group B showed 1493 DEGs, comprising 808 upregulated and 685 downregulated genes. Group C had 1466 DEGs, including 800 upregulated and 666 downregulated genes (Figure 3A). In the spleen, Group A displayed 567 DEGs, with 211 upregulated and 356 downregulated. Group B contained 2108 DEGs, with 891 upregulated and 1217 downregulated. Group C had 2842 DEGs, including 845 upregulated and 1997 downregulated genes (Figure 3B). In the liver, Group A showed 2489 DEGs, with 1325 upregulated and 1164 downregulated. Group B had 3198 DEGs, comprising 1358 upregulated and 1840 downregulated. Group C contained 1427 DEGs, with 870 upregulated and 557 downregulated (Figure 3C). A Venn diagram analysis of DEGs (Figure 4) indicated that the combined effect of avian leukemia virus and S. Pullorum infection on chickens was not simply additive across tissues. Co-infection with ALV and S. Pullorum likely induced combined or antagonistic interactions within the host, resulting in novel gene expression patterns distinct from those observed in single infections. Cluster analysis of these differentially expressed genes revealed that samples from the same group clustered together, indicating satisfactory gene clustering results and reasonable grouping within this sample set (Figure 5).

3.4. Functional Enrichment Analysis of Differentially Expressed Genes

GO functional enrichment analysis of differentially expressed genes yielded results categorized into three major groups: biological process, cellular component, and molecular function. The top 10 most significantly enriched functional categories within each group were selected for analysis. The results revealed that in the kidney (Figure 6), Group A’s upregulated genes were significantly enriched in the ribosome biosynthesis pathway, whilst downregulated genes were concentrated in the metabolism of exogenous substances and redox enzyme activity processes. In the spleen (Figure 7), Group A’s upregulated genes showed significant enrichment in enzyme inhibitor activity, whereas downregulated genes were markedly enriched in the regulation of endothelial cell proliferation and intercellular adhesion. In the liver (Figure 8), upregulated genes were significantly enriched in extracellular matrix processes, whilst downregulated genes showed significant enrichment in small molecule metabolism and peroxisome function. Conversely, the regulatory patterns of Groups B and C diverged from Group A’s multi-organ “synthetic activation and metabolic inhibition” combined regulatory pattern. In the kidney, Group B genes were significantly concentrated in chromosome segregation processes, whilst Group C genes clustered around oxidative phosphorylation. In the spleen and liver, the single-infection group primarily enriched pathways related to basal metabolism, such as cell acylamide metabolism, nucleotide metabolism, and specific cellular functions like ribosomal structure. Detailed data are presented in Appendix C and Appendix D.
Furthermore, KEGG enrichment analysis revealed the following: in renal tissue, differentially expressed genes in Group A were significantly enriched in three core pathways: immune and inflammatory responses (e.g., cytokine–cytokine receptor interactions), biosynthesis (e.g., ribosomes), and energy metabolism (e.g., oxidative phosphorylation). Conversely, the effects of single-infection groups were more targeted: Group B genes were primarily enriched in metabolic pathways such as steroid biosynthesis; Group C genes were concentrated in oxidative phosphorylation and the transforming growth factor-β signaling pathway. Inter-group differences revealed that compared to Group B, Group A’s differentially expressed genes predominantly enriched in steroid biosynthesis and PPAR signaling pathways; no significantly enriched pathways were observed between Groups A and C. In spleen tissue, no KEGG pathways reached the significance threshold for enrichment in Group A. Conversely, the effects of the single-infection group were pronounced: Group B’s differentially expressed genes were predominantly enriched in metabolic and biosynthetic pathways such as ribosome and oxidative phosphorylation; Group C exhibited widespread impacts on cellular structure and adhesion, with genes significantly enriched in pathways including cell adhesion molecules, focal adhesions, ECM–receptor interactions, and calcium signaling. Differences between Group A and Groups B/C were limited to pathways such as muscle cytoskeleton. In the liver, Group A differentially expressed genes were significantly enriched in a core metabolic regulatory cluster encompassing amino acid metabolism, fatty acid metabolism, peroxisome function, and PPAR signaling pathways (Figure 9). Both Groups B and C showed significant enrichment in numerous metabolism-related pathways, with Group C exhibiting the most extensive enrichment, spanning multiple levels from amino acid degradation to lipid metabolism. Compared to Group B, Group A exhibited more pronounced enrichment of differentially expressed genes in the PPAR signaling pathway and ECM–receptor interactions.

3.5. Screening of Candidate Genes

Based on differential gene expression analysis, with screening criteria of an adjusted p-value ≤ 0.05 and |log2(FoldChange)| ≥ 1, eight significantly differentially expressed genes were identified, comprising four downregulated genes and four upregulated genes. The specific screening results are as follows: SQLE (upregulated 4.8-fold), MSMO1 (upregulated 4.4-fold), FDFT1 (downregulated 7-fold), FOXG1 (downregulated 5.3-fold), LOC107049046 (downregulated 12-fold), MAPK10 (upregulated 4.8-fold), FN1 (upregulated 2.9-fold), and LOC101747704 (upregulated 5.8-fold). Functional annotation and pathway analysis revealed that these candidate genes were predominantly enriched in pathways including the extracellular matrix–receptor interaction pathway and the intercellular adhesion pathway.

3.6. RT-qPCR Validation of Differentially Expressed Genes

This study selected five differentially expressed genes for RT-qPCR validation (Figure 10). Results showed that MAPK10 was upregulated 4.8-fold, FOXG1 was downregulated 5.3-fold, FDFT1 was downregulated 7-fold, FN1 was upregulated 2.9-fold, and LOC107049046 was downregulated 12-fold. The log2FC values from transcriptome sequencing and qPCR were largely consistent, confirming the reliability of the transcriptome data.

4. Discussion

This study employed transcriptomic sequencing to profile gene expression changes in the kidneys, spleen, and liver of chickens under co-infection with ALV and S. pullorum, compared to single-infection and control groups. The results revealed distinct organ-specific transcriptional responses and identified key pathways and candidate genes potentially involved in the pathogenesis of co-infection.
Among the differentially enriched pathways, this study identified those significantly associated with cancer, tumorigenesis, and immune responses. In kidney tissues, genes differentially expressed in the co-infection group were enriched in pathways related to immune functions, such as the intestinal IgA production immune network [21], as well as metabolic processes including biosynthesis and metabolism of exogenous substances and redox enzyme activity. Notably, several ribosomal protein genes, including RPS3A [22] and RPL18A, showed downregulated expression. Literature indicates that some ribosomal proteins, such as RPL13A [23] and RPS3, have immunoregulatory roles [24,25]. In pathways involved in exogenous substance metabolism, significant changes were observed in cytochrome P450 genes like CYP2C23 and CYP1A, which are essential for renal metabolism [26]. In single-infection groups, the ALV-infected group mainly enriched pathways related to steroid and terpenoid biosynthesis, involving genes such as CYP51A1, DHCR24 [27], IDI2, and FDPS [28]. Conversely, the avian typhoid infection group primarily enriched the oxidative phosphorylation pathway [29].
In the spleen, genes differentially expressed in the co-infection group were enriched in functions related to the Notch signaling pathway, such as JAG1 downregulation [30], and regulation of endothelial cell proliferation, involving genes like IGF2 and NGFR [31,32]. In the ALV infection group, differentially expressed genes showed significant enrichment in calcium ion signaling pathways, ECM–receptor interactions, and MAPK signaling pathways, with altered expression of HRH1, CYSLTR2, and EDNRA [33]. The chicken white diarrhea infection group primarily exhibited enrichment in pathways including cell adhesion, focal adhesions, and ECM–receptor interactions, with genes such as COL1A1 [34] and MYL6 showing altered expression.
In the liver, differentially expressed genes from the co-infection group were extensively enriched across multiple metabolic pathways, including peroxisome function, amino acid and fatty acid metabolism, steroid biosynthesis, and PPAR signaling pathways [35]. Notably, genes like SQLE, MSMO1, FDFT1, and CYP51A1 displayed significant expression differences within the steroid synthesis pathway [36]. The enrichment patterns in single-infection groups showed similarities to those in the kidneys: the ALV-infected group was enriched in steroid hormone biosynthesis and PPAR signaling pathways, while the chicken typhoid-infected group was enriched in oxidative phosphorylation and respiratory electron transport chain pathways.
Furthermore, to clarify the specific effects of co-infection separate from single infections, we performed direct intergroup comparisons. Our analysis showed that in the kidneys, differentially expressed genes between the co-infection group (Group A) and the ALV-infected group (Group B) were significantly enriched in the PPAR signaling pathway. Notably, the rate-limiting enzyme genes ACOX1 [16] and CPT1A, which are involved in fatty acid oxidation within this pathway, showed downregulated expression. This indicates that co-infection and ALV monoinfection may regulate renal lipid metabolism through distinct molecular mechanisms. Detailed data are presented in Appendix E.
Across all three organs, eight candidate genes showed consistently significant expression changes in the co-infection group. These include upregulated SQLE, MSMO1, MAPK10, and LOC101747704, and downregulated FDFT1, FOXG1, LOC107049046, and FN1. Among these, MAPK10—a member of the JNK signaling pathway involved in apoptosis and inflammation—may play a role in co-infection-induced cellular stress responses. The unannotated genes LOC107049046 and LOC101747704, given their infection-specific and extreme expression patterns, warrant further investigation as potential novel regulators in avian co-infection. The remaining genes, particularly those involved in cholesterol metabolism (SQLE, MSMO1, FDFT1) and cell adhesion (FN1), provide promising directions for future functional studies.
In conclusion, this multi-organ transcriptomic analysis reveals that co-infection with ALV and S. Pullorum induces distinct molecular signatures not observed in single infections, with organ-specific pathway perturbations and a set of robust candidate genes. These findings provide a foundational framework for future studies aiming to dissect the mechanistic basis of co-infection pathogenesis and identify potential targets for intervention.
It should be noted that the sample size in this study (n = 3 per group) is relatively modest, which may constrain the statistical power and the extent to which the findings can be generalized. Although this sample size is commonly used in transcriptomic studies involving animal models due to practical and ethical considerations, future studies with larger cohorts are warranted to validate our key findings and further elucidate the biological mechanisms underlying ALV and S. Pullorum co-infection.

5. Conclusions

This study employed transcriptome sequencing technology to further investigate the molecular mechanisms underlying co-infection with ALV and S. pullorum, identifying multiple differentially expressed genes and pathways associated with immunity and tumourigenesis. Functional enrichment analysis revealed the crucial roles of pathways such as the PPAR signaling pathway and ECM–receptor interactions in the co-infection of ALV and S. pullorum. Candidate gene screening and real-time quantitative PCR validation further confirmed the potential functions of these genes. These findings provide a crucial molecular foundation for in-depth investigation into the regulatory mechanisms underlying the co-infection phenomenon of ALV and S. pullorum.

Author Contributions

M.T. conceived and designed the study, supervised the project, wrote and revised the manuscript, and acquired funding. R.R. performed the animal experiments and collected samples. C.L. conducted formal bioinformatics analysis and data visualization. T.X. contributed to methodology development, pathogen detection, and infection model validation. K.Z. assisted in data curation and manuscript review. Q.W. provided resources, oversaw project administration, and reviewed and finalized the manuscript. X.L. Provided funding support and performed final review of the manuscript. H.W. provided Project administration. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Project of Chongqing Municipal Key Project Task Book for Technological Innovation and Application Development (CSTB2025TIAD-KPX0069), the Chongqing Science and Enterprise Consortium Germplasm Resources Collection and Utilization and Variety Trial (KQ202301), the National Natural Science Foundation of China (31802054).

Institutional Review Board Statement

The Animal Ethics Committee of Southwestern University approved all animal procedures. (SWU_LAC2025111041 23 October 2025).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are openly available in the NCBI database under accession number PRJNA1247184.

Acknowledgments

We sincerely thank all colleagues who contributed to this research. Rong Ran performed the animal experiments and collected samples. Cheng Liu conducted formal bioinformatics analysis and data visualization. Tao Xie contributed to methodology development, pathogen detection, and infection model validation. Keshan Zhang assisted in data curation and manuscript review. Qigui Wang provided resources, oversaw project administration, and reviewed and finalized the manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A. Sequencing Quality Summary

Table A1. Summary of sequencing data quality for 36 samples.
Table A1. Summary of sequencing data quality for 36 samples.
Sampleraw_readsraw_basesclean_readsclean_baseserror_rateQ20Q30GC_pct
NCliver147,122,8387.07G45,702,8306.86G0.0199.0796.2549.74
NCspleen145,099,6166.76G43,751,9826.56G0.0198.6295.1849
NCkidney143,523,4426.53G41,990,0726.3G0.0198.9395.9348.47
NCliver245,149,8926.77G43,686,1186.55G0.0199.0996.3848.25
NCspleen245,865,9826.88G44,546,5466.68G0.0198.6995.3548.26
NCkidney244,313,6966.65G43,013,9006.45G0.0198.9395.9349.08
NCliver344,521,7626.68G43,435,6106.52G0.0198.9996.1549.07
NCspleen342,953,1546.44G41,824,5926.27G0.0198.7595.5348.11
NCkidney343,971,3846.6G42,581,2126.39G0.0198.995.8448.56
Coliver146,571,9706.99G42,862,2666.43G0.0198.5396.1250.03
Cospleen147,313,2167.1G44,073,9986.61G0.0198.596.0250.06
Cokidney146,780,0127.02G43,835,5966.58G0.0198.4896.0148.76
Coliver246,386,1926.96G42,679,2166.4G0.0198.3795.7549.7
Cospleen239,558,8745.93G35,798,0545.37G0.0198.4495.9343.41
Cokidney248,383,9187.26G44,105,5226.62G0.0198.6996.5549.31
Coliver345,346,5026.8G42,079,8766.31G0.0198.6496.3649.34
Cospleen353,856,7448.08G48,696,5347.3G0.0198.6196.3449.69
Cokidney343,133,1046.47G38,818,7605.82G0.0198.6596.3549.78
ALVliver147,082,0347.06G42,710,1606.41G0.0197.9994.7747.81
AlVspleen146,604,8806.99G45,630,2806.84G0.0397.7194.0150.61
ALVkidney143,504,6086.53G43,273,1946.49G0.0197.6194.0348.29
ALVliver246,063,9206.91G45,761,8886.86G0.0197.7894.4347.9
AlVspleen248,325,6267.25G48,056,2067.21G0.0198.6896.5449.77
ALVkidney247,124,0327.07G45,503,7846.83G0.0197.8294.4948.41
ALVliver346,886,3007.03G42,780,7766.42G0.0197.9494.7446.88
AlVspleen347,763,9447.16G47,493,9187.12G0.0198.6596.4949.48
ALVkidney349,016,2887.35G47,608,4687.14G0.0197.7794.3248.74
SPliver149,309,9407.4G45,788,3226.87G0.0198.4995.9549.04
SPspleen156,965,3148.54G55,605,9108.34G0.0397.2393.0951.37
SPkidney146,791,2387.02G42,784,0646.42G0.0198.6196.2750.15
SPliver248,055,5667.21G47,486,3427.12G0.0198.1795.4452.58
SPspleen249,245,7367.39G48,085,5227.21G0.0397.0892.950.99
SPkidney247,284,2907.09G42,577,4646.39G0.0198.4295.9146.53
SPliver347,099,9147.06G42,746,4826.41G0.0198.4696.0250.9
SPspleen347,335,9507.1G44,007,3646.6G0.0198.4595.9150.93
SPkidney349,532,9207.43G46,118,1126.92G0.0198.4295.9249.14

Appendix B. Statistics Table Showing the Alignment of Reads to the Reference Genome

Table A2. Statistics of reads alignment to the reference genome for 36 samples.
Table A2. Statistics of reads alignment to the reference genome for 36 samples.
Sampletotal_readstotal_mapunique_mapmulti_mapread1_mapread2_map
NCliver145,702,83042,369,669 (92.71%)40,856,549 (89.4%)1,513,120 (3.31%)20,492,174 (44.84%)20,364,375 (44.56%)
NCspleen143,751,98237,888,197 (86.6%)36,735,018 (83.96%)1,153,179 (2.64%)18,445,875 (42.16%)18,289,143 (41.8%)
NCkidney141,990,07238,429,474 (91.52%)37,543,778 (89.41%)885,696 (2.11%)18,838,369 (44.86%)18,705,409 (44.55%)
NCliver243,686,11840,964,593 (93.77%)39,713,532 (90.91%)1,251,061 (2.86%)19,913,920 (45.58%)19,799,612 (45.32%)
NCspleen244,546,54639,183,048 (87.96%)38,095,011 (85.52%)1,088,037 (2.44%)19,127,876 (42.94%)18,967,135 (42.58%)
NCkidney243,013,90039,142,310 (91.0%)38,197,259 (88.8%)945,051 (2.2%)19,174,461 (44.58%)19,022,798 (44.22%)
NCliver343,435,61039,792,800 (91.61%)38,439,477 (88.5%)1,353,323 (3.12%)19,284,490 (44.4%)19,154,987 (44.1%)
NCspleen341,824,59236,988,325 (88.44%)35,956,252 (85.97%)1,032,073 (2.47%)18,053,860 (43.17%)17,902,392 (42.8%)
NCkidney342,581,21238,804,192 (91.13%)37,884,522 (88.97%)919,670 (2.16%)19,013,484 (44.65%)18,871,038 (44.32%)
Coliver142,862,26638,763,208 (90.44%)36,185,439 (84.42%)2,577,769 (6.01%)18,172,977 (42.4%)18,012,462 (42.02%)
Cospleen144,073,99839,696,349 (90.07%)37,436,384 (84.94%)2,259,965 (5.13%)18,809,145 (42.68%)18,627,239 (42.26%)
Cokidney143,835,59640,597,072 (92.61%)37,176,493 (84.81%)3,420,579 (7.8%)18,685,423 (42.63%)18,491,070 (42.18%)
Coliver242,679,21639,033,426 (91.46%)37,583,939 (88.06%)1,449,487 (3.4%)18,905,843 (44.3%)18,678,096 (43.76%)
Cospleen235,798,05432,976,692 (92.12%)31,474,788 (87.92%)1,501,904 (4.2%)15,794,575 (44.12%)15,680,213(43.8%)
Cokidney244,105,52239,800,126 (90.24%)38,557,254 (87.42%)1,242,872 (2.82%)19,361,139 (43.9%)19,196,115 (43.52%)
Coliver342,079,87638,574,311 (91.67%)36,374,680 (86.44%)2,199,631 (5.23%)18,280,484 (43.44%)18,094,196 (43.0%)
Cospleen348,696,53443,174,258 (88.66%)41,867,891 (85.98%)1,306,367 (2.68%)21,029,074 (43.18%)20,838,817 (42.79%)
Cokidney338,818,76034,999,116 (90.16%)33,457,142 (86.19%)1,541,974 (3.97%)16817425 (43.32%)16,639,717 (42.87%)
ALVliver142,710,16038,331,689 (89.75%)36,364,508 (85.14%)1,967,181 (4.61%)18,209,389 (42.63%)18,155,119 (42.51%)
AlVspleen145,630,28041,072,961 (90.01%)39,790,131 (87.2%)1,282,830 (2.81%)19,959,354 (43.74%)19,830,777 (43.46%)
ALVkidney143,273,19437,626,261 (86.95%)35,111,071 (81.14%)2,515,190 (5.81%)17,652,033 (40.79%)17,459,038 (40.35%)
ALVliver245,761,88840,335,525 (88.14%)37,935,714 (82.9%)2,399,811 (5.24%)19,018,811 (41.56%)18,916,903 (41.34%)
AlVspleen248,056,20642,958,995 (89.39%)41,815,452 (87.01%)1,143,543 (2.38%)20,943,556 (43.58%)20,871,896 (43.43%)
ALVkidney245,503,78439,719,422 (87.29%)38,104,267 (83.74%)1,615,155 (3.55%)19,159,341 (42.1%)18,944,926 (41.63%)
ALVliver342,780,77638,186,042 (89.26%)36,426,385 (85.15%)1,759,657 (4.11%)18,237,858 (42.63%)18,188,527 (42.52%)
AlVspleen347,493,91843,301,247 (91.17%)40,764,003 (85.83%)2,537,244 (5.34%)20,406,461 (42.97%)20,357,542 (42.86%)
ALVkidney347,608,46841,175,348 (86.49%)39,385,541 (82.73%)1,789,807(3.76%)19,783,452 (41.55%)19,602,089 (41.17%)
SPliver145,788,32243,083,740 (94.09%)40,383,319 (88.2%)2,700,421 (5.9%)20,293,096 (44.32%)20,090,223 (43.88%)
SPspleen155,605,91049,682,454 (89.35%)47,716,412 (85.81%)1,966,042 (3.54%)23,975,454 (43.12%)23,740,958 (42.7%)
SPkidney142,784,06438,329,865 (89.59%)36,618,704 (85.59%)1,711,161 (4.0%)18,398,935 (43.0%)18,219,769 (42.59%)
SPliver247,486,34241,847,825 (88.13%)38,537,451 (81.15%)3,310,374 (6.97%)19,362,546 (40.77%)19,174,905 (40.38%)
SPspleen248,085,52242,902,808 (89.22%)41,147,678 (85.57%)1,755,130 (3.65%)20,675,946 (43.0%)20,471,732 (42.57%)
SPkidney242,577,46439,399,588 (92.54%)39,028,482 (91.66%)371,106 (0.87%)19,581,145 (45.99%)19,447,337 (45.68%)
SPliver342,746,48237,661,195 (88.1%)35,316,294 (82.62%)2,344,901 (5.49%)17,756,083 (41.54%)17,560,211 (41.08%)
SPspleen344,007,36439,407,403 (89.55%)36,748,025 (83.5%)2,659,378 (6.04%)18,476,637 (41.99%)18,271,388 (41.52%)
SPkidney346,118,11242,972,879 (93.18%)40,123,808 (87.0%)2,849,071 (6.18%)20,158,553 (43.71%)19,965,255 (43.29%)

Appendix C. GO Enrichment of Significantly DEGs in the Avian Leukosis Virus-Infected Group

Figure A1. GO enrichment analysis of significantly differentially expressed genes in the avian leukosis virus-infected group, shown for the kidney (A), spleen (B), and liver (C), respectively.
Figure A1. GO enrichment analysis of significantly differentially expressed genes in the avian leukosis virus-infected group, shown for the kidney (A), spleen (B), and liver (C), respectively.
Vetsci 13 00283 g0a1

Appendix D. GO Enrichment Analysis of Significantly Differentially Expressed Genes in the Salmonella pullorum-Infected Group

Figure A2. GO enrichment analysis of significantly differentially expressed genes in the kidney(A), spleen(B), and liver(C) of the Salmonella pullorum-infected group, respectively.
Figure A2. GO enrichment analysis of significantly differentially expressed genes in the kidney(A), spleen(B), and liver(C) of the Salmonella pullorum-infected group, respectively.
Vetsci 13 00283 g0a2

Appendix E. KEGG Pathway Analysis of the Co-Infection Group Compared with Single-Infection Groups

Figure A3. KEGG Pathway Diagram for the Co-Infection Group Compared with the Avian Leukosis Virus Infection Group and the Pullorum Disease Infection Group, Respectively. (A) Kidney; (B) Spleen; (C) Liver.
Figure A3. KEGG Pathway Diagram for the Co-Infection Group Compared with the Avian Leukosis Virus Infection Group and the Pullorum Disease Infection Group, Respectively. (A) Kidney; (B) Spleen; (C) Liver.
Vetsci 13 00283 g0a3

References

  1. Xu, M. A Study on the Molecular Epidemiology and Biological Characteristics of Avian Leukosis Virus Subgroup J in East China from 2017 to 2022. Master’s thesis, Yangzhou University, Yangzhou, China, 2023. (In Chinese) [Google Scholar]
  2. Lu, Q.; Luo, Q.; Zhang, T. Pathogenicity and biological characteristics of the RcsB protein from S. pullorum. Chin. Poult. 2019, 41, 17–21. (In Chinese) [Google Scholar]
  3. Chen, Q. Epidemiological Survey of Avian Leukemia and Chicken Dysentery in Different Chicken Breeds in Huishui County. Master’s Thesis, Guizhou University, Guiyang, China, 2021. (In Chinese) [Google Scholar]
  4. Han, Z.; Zhang, N.; Wang, X. A Brief Discussion on the Diagnosis and Prevention Techniques for Chicken White Diarrhoea. Poult. Sci. 2022, 7, 25–26. (In Chinese) [Google Scholar]
  5. Luan, Y. Biological Characteristics of Live Vaccine Against Enteritis Salmonella and Evaluation of Its Efficacy Against Early Infection by S. pullorum. Master’s Thesis, Shandong Agricultural University, Tai’an, China, 2023. (In Chinese) [Google Scholar]
  6. Yin, J.; Wu, Y.; Lin, Z.; Wang, X. Construction and Biological Characteristics of a Pathogenic Island-2 Deleted Strain of S. pullorum S06004. Acta Microbiol. Sin. 2015, 55, 1154–1159. (In Chinese) [Google Scholar]
  7. Yin, J. Pathogenicity and Immunological Effects of S. pullorum T3SS2 and Its Effector Protein CigR. Master’s Thesis, Yangzhou University, Yangzhou, China, 2016. (In Chinese) [Google Scholar]
  8. Li, C. Epidemiological Survey of S. pullorum in the East China Region during 2019–2020 and Evaluation of Immunogenicity of the Live Attenuated Vaccine against S. pullorum. Master’s Thesis, Yangzhou University, Yangzhou, China, 2021. (In Chinese) [Google Scholar]
  9. Shi, X.H. Treatment Protocols and Prevention Measures for Chicken White Diarrhoea. Agric. Eng. Technol. 2024, 44, 114–115. (In Chinese) [Google Scholar]
  10. Fan, J.; Yu, Y.; Zhang, Y. Current Status and Recommendations for Avian Influenza Type H5N1 and Newcastle Disease Purification in China’s Breeding Flocks. Poult. Breed. Dis. Prev. 2024, 4, 22–24. (In Chinese) [Google Scholar]
  11. Huang, J. Mixed Infection of Chicken Leukemia Virus and S. pullorum. Ph.D. Thesis, Shandong Agricultural University, Tai’an, China, 2013. (In Chinese) [Google Scholar]
  12. Zhang, H.; Chen, Q. Advances in Research on Avian Leukemia and Its Diagnostic and Therapeutic Techniques. China Anim. Quar. 2017, 34, 78–81. (In Chinese) [Google Scholar]
  13. Yao, T.; Li, X.; Liu, J. Occurrence and Management of S. pullorum in Chickens. Agric. Eng. Technol. 2024, 44, 121–122. (In Chinese) [Google Scholar]
  14. Jing, Y.; Li, Y.; Xin, J.; Chai, J. Co-infection of ALV-J and Salmonella pullorum in laying hens. Pak. Vet. J. 2014, 34, 372–376. [Google Scholar]
  15. Tang, Y.; Foster, N.; Jones, M.A.; Barrow, P.A. Model of Persistent Salmonella Infection: Salmonella enterica Serovar Pullorum Modulates the Immune Response of the Chicken from a Th17-Type Response towards a Th2-Type Response. Infect. Immun. 2018, 86, e00307-18. [Google Scholar] [CrossRef]
  16. Chen, S.; Xu, H.; Li, W.; Nie, Y.; Xie, Q.; Chen, W. Deciphering Immune Modulation in Chickens Co-Infected with ALV-J and CIAV: A Transcriptomic Approach. Microorganisms 2024, 12, 2453. [Google Scholar] [CrossRef]
  17. He, S.; Zheng, G.; Zhou, D.; Huang, L.; Dong, J.; Cheng, Z. High-frequency and activation of CD4(+)CD25(+) T cells maintain persistent immunotolerance induced by congenital ALV-J infection. Vet. Res. 2021, 52, 119. [Google Scholar] [CrossRef] [PubMed]
  18. Dai, J.; Zhou, P.; Li, S.; Qiu, H.J. Crosstalk between interferon and inflammatory signaling pathways in the immune responses to viral infections: Defense and homeostasis. Acta Microbiol. Sin. 2022, 62, 3709–3721. [Google Scholar]
  19. Saade, G.; Deblanc, C.; Bougon, J.; Marois-Créhan, C.; Fablet, C.; Auray, G.; Belloc, C.; Leblanc-Maridor, M.; Gagnon, C.A.; Zhu, J.; et al. Coinfections and their molecular consequences in the porcine respiratory tract. Vet. Res. 2020, 51, 80. [Google Scholar] [CrossRef] [PubMed]
  20. Lan, X.; Wang, Y.; Tian, K.; Ye, F.; Yin, H.; Zhao, X.; Xu, H.; Huang, Y.; Liu, H.; Hsieh, J.C.F.; et al. Integrated host and viral transcriptome analyses reveal pathology and inflammatory response mechanisms to ALV-J injection in SPF chickens. Sci. Rep. 2017, 7, 46156. [Google Scholar] [CrossRef] [PubMed]
  21. Yang, N. Global Trends, Challenges and Technical Countermeasures in the Poultry Industry. North. Anim. Husb. 2019, 4, 6–7. (In Chinese) [Google Scholar]
  22. Saha, A.; Das, S.; Moin, M.; Dutta, M.; Bakshi, A.; Madhav, M.S.; Kirti, P.B. Genome-Wide Identification and Comprehensive Expression Profiling of Ribosomal Protein Small Subunit (RPS) Genes and their Comparative Analysis with the Large Subunit (RPL) Genes in Rice. Front. Plant Sci. 2017, 8, 1553. [Google Scholar] [CrossRef]
  23. De Luca, C.; Hess, M. Vaccination strategies to protect chickens from fowl adenovirus (FAdV)-induced diseases: A comprehensive review. Vaccine 2025, 43, 126496. [Google Scholar] [CrossRef]
  24. Zhou, X.; Liao, W.-J.; Liao, J.-M.; Liao, P.; Lu, H. Ribosomal proteins: Functions beyond the ribosome. J. Mol. Cell Biol. 2015, 7, 92–104. [Google Scholar] [CrossRef]
  25. Geng, Y.; Du, H.; Liu, L. Advances in Research on Post-Translational Modifications and Physiological and Pathological Functions of RelA, a Member of the NF-κB Family. Life Sci. 2020, 32, 431–438. (In Chinese) [Google Scholar]
  26. Watanabe, K.P.; Kawai, Y.K.; Ikenaka, Y.; Kawata, M.; Ikushiro, S.; Sakaki, T.; Ishizuka, M. Avian cytochrome P450 (CYP) 1-3 family genes: Isoforms, evolutionary relationships, and mRNA expression in chicken liver. PLoS ONE 2013, 8, e75689. [Google Scholar] [CrossRef]
  27. Muret, K.; Klopp, C.; Wucher, V.; Esquerré, D.; Legeai, F.; Lecerf, F.; Désert, C.; Boutin, M.; Jehl, F.; Acloque, H.; et al. Long noncoding RNA repertoire in chicken liver and adipose tissue. Genet. Sel. Evol. 2017, 49, 6. [Google Scholar] [CrossRef]
  28. Guerra, B.; Recio, C.; Aranda-Tavío, H.; Guerra-Rodríguez, M.; García-Castellano, J.M.; Fernández-Pérez, L. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy. Front. Oncol. 2021, 11, 626971. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, S.; Xiao, J.; Jin, M. Cholesterol Metabolism and Immune Response. Biomed. Transl. 2024, 5, 36–45. (In Chinese) [Google Scholar]
  30. Neves, J.; Parada, C.; Chamizo, M.; Giráldez, F. Jagged 1 regulates the restriction of Sox2 expression in the developing chicken inner ear: A mechanism for sensory organ specification. Development 2011, 138, 735–744. [Google Scholar] [CrossRef]
  31. Yang, M.; Zhan, Y.; Hou, Z.; Wang, C.; Fan, W.; Guo, T.; Li, Z.; Fang, L.; Lv, S.; Li, S.; et al. VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function. Front. Oncol. 2022, 12, 887035. [Google Scholar] [CrossRef]
  32. Salmeron, C.; Sriram, K.; Javadi-Paydar, M.; Insel, P.A. Abstract PO-091: Histamine receptor 1 (HRH1): A potentially novel G protein-coupled receptor (GPCR) therapeutic target in pancreatic adenocarcinoma (PDAC) cells and tumors. Cancer Res. 2021, 81, PO-091. [Google Scholar] [CrossRef]
  33. Mukhopadhyay, D.; Goel, H.L.; Xiong, C.; Goel, S.; Kumar, A.; Li, R.; Zhu, L.J.; Clark, J.L.; Brehm, M.A.; Mercurio, A.M. The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin α6 mRNA splicing. Cell Rep. 2023, 42, 113347. [Google Scholar] [CrossRef]
  34. Sun, T.; Xiao, C.; Yang, Z.; Deng, J.; Yang, X. Transcriptome profiling analysis of uterus during chicken laying periods. BMC Genom. 2023, 24, 433. [Google Scholar] [CrossRef]
  35. Li, R.; Cao, R.; Peng, Y.; Gan, X.; Zhang, Y.; Gu, T.; Xu, W.; Su, J.; Tian, Y.; Zeng, T.; et al. Integrated transcriptomic and metabolomic profiling deciphers breed-, age-, and rearing system-dependent regulation of muscle development and meat quality in chickens. Food Chem. Mol. Sci. 2026, 12, 100369. [Google Scholar] [CrossRef] [PubMed]
  36. Zou, C.; Jiang, H.; Wu, X.; Gao, J.; Ma, W. Integrative analysis of metabolomics and transcriptomics reveals alterations in egg quality and hepatic lipid metabolism in hens supplemented with curcumin. Anim. Nutr. 2025, 21, 302–314. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Correlation analysis between samples. Pearson correlation analysis heatmap of different organizational samples (A) and principal component analysis of different organizational samples (B).
Figure 1. Correlation analysis between samples. Pearson correlation analysis heatmap of different organizational samples (A) and principal component analysis of different organizational samples (B).
Vetsci 13 00283 g001aVetsci 13 00283 g001b
Figure 2. Co-expression Venn analysis of three different treatment samples in kidney (A), spleen (B) and liver (C).
Figure 2. Co-expression Venn analysis of three different treatment samples in kidney (A), spleen (B) and liver (C).
Vetsci 13 00283 g002
Figure 3. Analysis of differentially expressed genes. Volcano plots of differentially expressed genes (AC).
Figure 3. Analysis of differentially expressed genes. Volcano plots of differentially expressed genes (AC).
Vetsci 13 00283 g003
Figure 4. Analysis of differentially expressed genes. (AC) Venn diagrams showing differentially expressed genes in the kidney, spleen, and liver, respectively.
Figure 4. Analysis of differentially expressed genes. (AC) Venn diagrams showing differentially expressed genes in the kidney, spleen, and liver, respectively.
Vetsci 13 00283 g004
Figure 5. Cluster analysis of differentially expressed genes.
Figure 5. Cluster analysis of differentially expressed genes.
Vetsci 13 00283 g005
Figure 6. GO enrichment results of significantly differentially expressed genes in the kidney within the mixed-infection group. (A) Enrichment analysis of up-regulated genes; (B) Enrichment analysis of down-regulated genes.
Figure 6. GO enrichment results of significantly differentially expressed genes in the kidney within the mixed-infection group. (A) Enrichment analysis of up-regulated genes; (B) Enrichment analysis of down-regulated genes.
Vetsci 13 00283 g006
Figure 7. GO enrichment results of significantly differentially expressed genes in the spleen within the mixed-infection group. (A) Enrichment analysis of up-regulated genes; (B) Enrichment analysis of down-regulated genes.
Figure 7. GO enrichment results of significantly differentially expressed genes in the spleen within the mixed-infection group. (A) Enrichment analysis of up-regulated genes; (B) Enrichment analysis of down-regulated genes.
Vetsci 13 00283 g007
Figure 8. GO enrichment results of significantly differentially expressed genes in the liver within the mixed-infection group. (A) Enrichment analysis of up-regulated genes; (B) Enrichment analysis of down-regulated genes.
Figure 8. GO enrichment results of significantly differentially expressed genes in the liver within the mixed-infection group. (A) Enrichment analysis of up-regulated genes; (B) Enrichment analysis of down-regulated genes.
Vetsci 13 00283 g008
Figure 9. KEGG pathway enrichment analysis of differentially expressed genes. Bar charts (AC) respectively present the KEGG enrichment results for differentially expressed genes in the kidneys, spleen, and liver within the co-infection group.
Figure 9. KEGG pathway enrichment analysis of differentially expressed genes. Bar charts (AC) respectively present the KEGG enrichment results for differentially expressed genes in the kidneys, spleen, and liver within the co-infection group.
Vetsci 13 00283 g009aVetsci 13 00283 g009b
Figure 10. This is a validation diagram for a differentially expressed gene.
Figure 10. This is a validation diagram for a differentially expressed gene.
Vetsci 13 00283 g010
Table 1. Principal reagents and consumables for the experiments.
Table 1. Principal reagents and consumables for the experiments.
Consumables NameManufacturer
Sterile PE glovesGuangming, Shenzhen, China
Disposable Nitrile GlovesBioshar, Hefei, China
Face MaskBiosharp, Hefei, China
RNA Preservation SolutionSolarbio, Beijing, China
Aluminum FoilClinlay, Shanghai, China
Surgical ScissorsCorning, Corning, NY, USA
PBS BufferSolarbio, Beijing, China
Blood Collection TubesJunuo, Taizhou, China
200 μL,1.5 mL Blood Collection TubesAxygen, Union City, CA, USA
10 μL, 200 μL, 1000 μL RNase-Free Pipette TipsBiosharp, Hefei, China
Table 2. Principal Experimental Apparatus.
Table 2. Principal Experimental Apparatus.
Instruments NameManufacturer
Bench-top High-speed Refrigerated CentrifugeEppendorf, Hamburg, Germany
Real-time Quantitative PCR SystemBio-Rad, Hercules, CA, USA
Thermostatic Magnetic StirrerEppendorf, Hamburg, Germany
Ultra-low Temperature FreezerSanyo, Osaka, Japan
Full-wavelength Microplate ReaderBio-Rad, Hercules, CA, USA
Pure Water Distillation SystemMillipore, Saint Louis, MO, USA
Thermostatic Shaker IncubatorBinder, Neckarsulm, Germany
Personal ComputerMicrosoft, Redmond, WA, USA
NanodropThermo Fisher Scientific, Waltham, MA, USA
Table 3. Transcriptome Primer Design Sequence.
Table 3. Transcriptome Primer Design Sequence.
GeneForward Primer (5′→3′)Reverse Primer (5′→3′)
FDFT1F: GAGGGGTGGTGAAGATTCGGR: CAAGGGACAGCCAAGTCCAC
MAPK10F: ACCATTGAGGAGTGGAAAGAACTR: CACCTGAAGGAGATGGCTGT
FOXG1F: CGATAGACTCGTCAACGGGGR: GTTCACGGAGCAGGGGTTTA
FN1F: TTGGAGAGCAGTGGCAGAAGR: GGCAGTTGACGTTGGTGTTT
LOC107049046F: GTGAGCAGGCAAAGGGGTTAR: TTTACTCCCGAGCCATCAGC
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tan, M.; Ran, R.; Liu, C.; Xie, T.; Zhang, K.; Wang, Q.; Lan, X.; Wang, H. Preliminary Transcriptomic Insights into the Combined Pathogenesis of Avian Leukosis Virus and Salmonella pullorum Co-Infection. Vet. Sci. 2026, 13, 283. https://doi.org/10.3390/vetsci13030283

AMA Style

Tan M, Ran R, Liu C, Xie T, Zhang K, Wang Q, Lan X, Wang H. Preliminary Transcriptomic Insights into the Combined Pathogenesis of Avian Leukosis Virus and Salmonella pullorum Co-Infection. Veterinary Sciences. 2026; 13(3):283. https://doi.org/10.3390/vetsci13030283

Chicago/Turabian Style

Tan, Min, Rong Ran, Cheng Liu, Tao Xie, Keshan Zhang, Qigui Wang, Xi Lan, and Haiwei Wang. 2026. "Preliminary Transcriptomic Insights into the Combined Pathogenesis of Avian Leukosis Virus and Salmonella pullorum Co-Infection" Veterinary Sciences 13, no. 3: 283. https://doi.org/10.3390/vetsci13030283

APA Style

Tan, M., Ran, R., Liu, C., Xie, T., Zhang, K., Wang, Q., Lan, X., & Wang, H. (2026). Preliminary Transcriptomic Insights into the Combined Pathogenesis of Avian Leukosis Virus and Salmonella pullorum Co-Infection. Veterinary Sciences, 13(3), 283. https://doi.org/10.3390/vetsci13030283

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop